Catalyst Wire Dossier Catalyst Wire Dossier

ZYCUBO

copper histidinate · Sentynl Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZYCUBO, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: FDA Approved: ZYCUBO — Original Application (Sentynl Therapeutics, Inc.)

See pricing